Results 261 to 270 of about 7,676,849 (387)

Revealing the Patient Perspective: Evolution of Patient-Reported Outcome Measures in Botulinum Toxin Studies in Aesthetic Medicine. [PDF]

J Cosmet Dermatol
Dayan S, Rivkin AZ, Ogilvie P, Carruthers JDA, Wu Y, Lee E, Patel V, Musumeci M.   +7 more
europepmc   +1 more source

775 Comparison of Self-reported Outcomes of Pediatric and Adult Patients with Phrenic Nerve Stimulators

, 2004
Stephen I. Ryu, Daniel H. Kim, Ho-Yeol Zhang   +2 more
openalex   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

PDB23 IS PSYCHOLOGICAL GENERAL WELL-BEING AN IMPORTANT PATIENT-REPORTED OUTCOME FOR THE EVALUATION OF DIABETES DRUG THERAPY?

, 2004
RP Hayes, Lee Bowman
openalex   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

Coaching Patients to Understand and Use Patient-Reported Outcome Data: Intervention Design and Evaluation. [PDF]

JMIR Form Res
Burla M, Stern BZ, Berry AB, Pila S, Franklin PD.   +4 more
europepmc   +1 more source

PPN9 AGREEMENT BETWEEN PATIENTS' AND CLINICIANS'- REPORTED OUTCOMES IN 3 CHRONIC DISEASES

, 2004
O Chassany, P. Le Jeunne
openalex   +1 more source

Raphin‐1 mediates the survival and sensitivity to radiation of pediatric‐type diffuse high‐grade glioma via phosphorylated eukaryotic initiation factor 2α‐dependent and ‐independent processes

Molecular Oncology, EarlyView.
Raphin‐1 reduces the survival of PED‐DHGG cells and enhances their radiation sensitivity through both PeIF2α‐dependent and PeIF2α‐independent mechanisms. Raphin‐1 sustains elevated levels of PeIF2α, contributing to its PeIF2α‐dependent effects. Additionally, raphin‐1 interacts with CReP to mediate a separate radiosensitizing pathway that operates ...
Karin Eytan, Moshe Leitner, Amos Toren, Shoshana Paglin, Michal Yalon   +4 more
wiley   +1 more source

Patient-reported outcome measurements in clinical trials in Saudi Arabia: A cross-sectional analysis of ClinicalTrials.gov. [PDF]

Saudi Med J
Al-Aqeel SA, AlKofide HA.
europepmc   +1 more source

PMD18 REAL-LIFE PATIENT REPORTED OUTCOMES: DATA MINING OF CONSUMER SPONTANEOUS REPORTS FOR TWO STATINS

, 2004
MW Reynolds, Steven J. Ross, K Fahrbach, David Frame, Katherine M. James   +4 more
openalex   +1 more source